See up to 3 months of PALI. The 7-day demo opens the 1M and 3M ranges and puts PALI on your watchlist.
Start 7-day demoLatest PALI insider trades
About PALISADE BIO, INC. (PALI)
PALISADE BIO, INC. is an SEC registrant, filing under CIK 0001357459, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
PALI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 20,000 | $29K |
| Option exercise | 6 | 11,696,468 | |
| Tax withholding / forfeiture | 2 | 2,443,084 | |
PALI insider transactions (Form 4)
5736 Form 4 filings on record, the earliest from Nov 22, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mitchell Lawrence Jones - Officer | Option exercise | Common Stock | 2,620,850 | - footnote F1 | - | |
| Mitchell Lawrence Jones - Officer | Tax withholding / forfeiture | Common Stock | 1,031,102 | $1.49 | $1.54M | |
| Mitchell Lawrence Jones - Officer | Option exercise | Restricted Stock Units | 2,555,266 | $0.00 | - | |
| Mitchell Lawrence Jones - Officer | Option exercise | Restricted Stock Units | 65,584 | $0.00 | - | |
| ||||||
 John David Finley - Officer | Option exercise | Common Stock | 3,227,384 | - footnote F1 | - | |
| John David Finley - Officer | Tax withholding / forfeiture | Common Stock | 1,411,982 | $1.49 | $2.10M | |
| John David Finley - Officer | Option exercise | Restricted Stock Units | 3,059,800 | $0.00 | - | |
| John David Finley - Officer | Option exercise | Restricted Stock Units | 167,584 | $0.00 | - | |
| ||||||
| Donald Allen Williams - Director | Open-market purchase | Common Stock | 10,000 | $1.42 | $14K | |
| Donald Allen Williams - Director | Open-market purchase | Common Stock | 10,000 | $1.46 | $15K | |
| John David Finley - Officer | Gift | Common Stock | 88,400 | $0.00 | - | |
| John David Finley - Officer | Gift | Common Stock | 88,400 | $0.00 | - | |
| Robert Baltera Jr. - Director | Open-market purchase | Common Stock | 20,000 | $1.99 footnote F1 | $40K | |
| Robert Baltera Jr. - Director | Open-market purchase | Common Stock | 25,000 | $1.96 footnote F2 | $49K | |
| ||||||
| Robert Baltera Jr. - Director | Open-market purchase | Common Stock | 20,000 | $2.05 footnote F1 | $41K | |
| Robert Baltera Jr. - Director | Open-market purchase | Common Stock | 30,000 | $2.03 footnote F2 | $61K | |
| ||||||
| Mitchell Lawrence Jones - Officer | Option exercise | Common Stock | 131,167 | - footnote F1 | - | |
| Mitchell Lawrence Jones - Officer | Open-market sale | Common Stock | 51,880 | $2.05 footnote F4 | $107K | |
| Mitchell Lawrence Jones - Officer | Option exercise | Restricted Stock Units | 131,167 | $0.00 | - | |
| ||||||
| John David Finley - Officer | Option exercise | Common Stock | 133 | $0.70 | $93 | |
| John David Finley - Officer | Option exercise | Common Stock | 335,167 | - footnote F1 | - | |
| John David Finley - Officer | Open-market sale | Common Stock | 146,798 | $2.07 footnote F4 | $303K | |
| John David Finley - Officer | Option exercise | Restricted Stock Units | 335,167 | $0.00 | - | |
| John David Finley - Officer | Option exercise | Series 2 Common Stock Purchase Warrant | 133 footnote F9 | $0.00 | - | |
| ||||||
| Robert Baltera Jr. - Director | Open-market purchase | Common Stock | 20,000 | $1.98 footnote F1 | $40K | |
| Robert Baltera Jr. - Director | Open-market purchase | Common Stock | 10,000 | $1.98 footnote F1 | $20K | |
| ||||||
| Robert Baltera Jr. - Director | Grant or award | Common Stock | 336,904 | - footnote F1 | - | |
| ||||||
| Binxian Wei - Director | Grant or award | Common Stock | 592,300 | - footnote F1 | - | |
| Binxian Wei - Director | Option exercise | Common Stock | 20,200 | - footnote F2 | - | |
| Binxian Wei - Director | Option exercise | Restricted Stock Units | 20,200 | $0.00 | - | |
| ||||||
| Donald Allen Williams - Director | Option exercise | Restricted Stock Units | 60,666 | $0.00 | - | |
| Donald Allen Williams - Director | Grant or award | Common Stock | 1,498,900 | - footnote F1 | - | |
| Donald Allen Williams - Director | Option exercise | Common Stock | 60,666 | - footnote F2 | - | |
| ||||||
| Emil Chuang - Director | Option exercise | Common Stock | 20,200 | - footnote F2 | - | |
| Emil Chuang - Director | Option exercise | Restricted Stock Units | 20,200 | $0.00 | - | |
| Emil Chuang - Director | Grant or award | Common Stock | 592,300 | - footnote F1 | - | |
| ||||||
| Jordan Michael Zwick - Director | Grant or award | Common Stock | 336,904 | - footnote F1 | - | |
| ||||||
| Mitchell Lawrence Jones - Officer | Option exercise | Common Stock | 8,000 | - footnote F1 | - | |
| Mitchell Lawrence Jones - Officer | Open-market sale | Common Stock | 1,989 | $1.75 | $3K | |
| Mitchell Lawrence Jones - Officer | Option exercise | Restricted Stock Units | 8,000 | $0.00 | - | |
| ||||||
| John David Finley - Officer | Option exercise | Common Stock | 13,333 | - footnote F1 | - | |
| John David Finley - Officer | Open-market sale | Common Stock | 3,896 | $1.75 | $7K | |
| John David Finley - Officer | Option exercise | Restricted Stock Units | 13,333 | $0.00 | - | |
| ||||||
| Mitchell Lawrence Jones - Officer | Grant or award | Restricted Stock Units | 787,000 | $0.00 | - | |
| John David Finley - Officer | Grant or award | Restricted Stock Units | 2,011,000 | $0.00 | - | |
| Donald Allen Williams - Director | Open-market purchase | Common Stock | 5,000 | $1.67 | $8K | |
| Donald Allen Williams - Director | Open-market purchase | Common Stock | 5,000 | $1.88 | $9K | |
| Donald Allen Williams - Director | Grant or award | Restricted Stock Units | 182,000 | $0.00 | - | |
| Binxian Wei - Director | Grant or award | Restricted Stock Units | 60,600 | $0.00 | - | |
| Emil Chuang - Director | Grant or award | Restricted Stock Units | 60,600 | $0.00 | - | |
| Donald Allen Williams - Director | Grant or award | Restricted Stock Units | 1,538,700 | $0.00 | - | |
| Binxian Wei - Director | Grant or award | Restricted Stock Units | 510,700 | $0.00 | - | |
| Mitchell Lawrence Jones - Officer | Grant or award | Restricted Stock Units | 7,665,800 | $0.00 | - | |
| John David Finley - Officer | Grant or award | Restricted Stock Units | 9,179,400 | $0.00 | - | |
| Emil Chuang - Director | Grant or award | Restricted Stock Units | 510,700 | $0.00 | - | |
| Donald Allen Williams - Director | Grant or award | Phantom Units | 64,400 | $0.00 | - | |
| Binxian Wei - Director | Grant or award | Phantom Units | 18,800 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02, 5.03, 5.07, 9.01
Item 2.02, 9.01
Item 8.01
Recent PALI Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
PALI insider trading FAQ
What is the latest insider trade for PALI?
PALISADE BIO, INC. (PALI) had 4 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for PALI runs to 36 Form 4 filings, the earliest from 2024-11-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PALI stock?
2 insider purchases of PALI were filed in the last 90 days, totaling $29K.
How many insiders are selling PALI stock?
No insider sales of PALI were filed in the last 90 days. 4 sales are on record for this company.
Where can I see PALI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PALI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mitchell Lawrence Jones view on EDGAR
- - John David Finley view on EDGAR
- - Donald Allen Williams view on EDGAR
- - John David Finley view on EDGAR
- - Robert Baltera Jr. view on EDGAR
- - Robert Baltera Jr. view on EDGAR
- - Mitchell Lawrence Jones view on EDGAR
- - John David Finley view on EDGAR
- - Robert Baltera Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PALI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PALI with a 7-day demo
- PALI on your watchlist
- Every PALI Form 4 filing on record
- Up to 3 months of PALI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
